MAOA and Alzheimer disease: In contrast to the current in vitro autoradiography study, binding studies with [3H]AV1451 on AD brain homogenates showed 10% displacement by the MAO-B inhibitor deprenyl and 80% (Ki = 0.70 nM) by the MAO-A inhibitor clorgyline [24].